Combinations of RAS Pathway Inhibitors with Targeted Agents Are Active in Spheroids of Patient-Derived Cells with Oncogenic KRAS Variants from Multiple Cancer TypesZahra Davoudi, Thomas S. Dexheimer,Nathan P. Coussens,Thomas Silvers,Joel Morris,Naoko Takebe,James H. Doroshow,Beverly A. Teichercrossref（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
